Goldberg Mark Alan

Track

Insider profile

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Goldberg Mark Alan's trades of ImmunoGen Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US ImmunoGen Inc (IMGN)
Transaction date
Proposed sale
Price
149.05
Quantity 8,234
Value US$1,543,982
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-10-30 2023-10-30
US ImmunoGen Inc (IMGN)
PrS Proposed sale
8,234
149.05
US$1,543,982 		8,234 149.05 US$1,543,982
2022-03-07 2022-03-03
B Purchase
75,984 +14.7%
96.38
US$3,172,729 		75,984 +14.7% 96.38 US$3,172,729
2020-12-28 2020-12-24
PlS Planned sale
37,275 +19.8%
273.09
US$1,562,853 		37,275 +19.8% 273.09 US$1,562,853
2020-12-22 2020-12-18
PlS Planned sale
5,454 -60.5%
120.00
US$654,480 		5,454 -60.5% 120.00 US$654,480
2020-12-15 2020-12-11
PlS Planned sale
5,455 -60.5%
115.00
US$627,325 		5,455 -60.5% 115.00 US$627,325
2020-12-03 2020-12-01
PlS Planned sale
5,454 -60.5%
110.00
US$599,940 		5,454 -60.5% 110.00 US$599,940
2020-10-21 2020-10-19
PlS Planned sale
5,455 -60.5%
105.00
US$572,775 		5,455 -60.5% 105.00 US$572,775
2020-10-09 2020-10-07
PlS Planned sale
5,454 -60.5%
100.00
US$545,400 		5,454 -60.5% 100.00 US$545,400